Intro to Pharm Flashcards
Examples of biologics
Hormones, vaccines, interferons, monoclonal antibodies, and natural blood products
What organization overlooks complementary and alternative medicine (CAM)?
National Center for Complementary and Alternative Medicine (NCCAM)
List subgroups of the FDA:
-Center for Drug Evaluation and Research (CDER)
-Center for Biologics Evaluation and Research (CBER)
-Center for Food Safety and Applied Nutrition (CFSAP)
CDER
Determines correct use of prescription and OTC agents
keeps unsafe and ineffective drugs from being marketed
CBER
Control biologics
-Childhood Vaccine Act of 1986: authorized FDA to collect info about patients receiving vaccines
CFSAP
Control herbal products and dietary supplements
-also regulated by dietary supplemental health and education act of 1994
-can still be marketed without FDA approval (monitored after distribution by FDA)
4 phases of drug development:
Phase I: Preclinical Investigation (1-3 years)
Phase II: Clinical Investigation (2-10 years)
-clinical phase 1,2,3
Phase III: Review of New Drug Application (NDA)
-2 months to 7 years
Phase IV: postmarketing surveillance
Phase I: Preclinical Investigation
-Extensive research on human and microbial cells in lab
-cultured cells and animal studies used to determine dosages, effectiveness, adverse effects
-obtain animal pharmacology and toxicology data
Phase II: Clinical Investigation: Phase I Trials
-several months
-20-100 human volunteers with disease/condition
-trade name developed
-sub-therapeutic doses used then increased
-safety and effectiveness
-70% of drugs move onto the next phase
Phase II: Clinical Investigation: Phase II Trials
-Several months-2 years
-several dozen-300 volunteers with disease/condition
-assess effectiveness, interactions with other meds, differences in effects on diff patients
-33% move on
Phase II: Clinical Investigation: Phase III Trials
1-4 years
-several hundred-3000 volunteers
-drug now assumed to have therapeutic effect
-if no serious adverse effects, drug could be quickly approved with careful monitoring
-25-30% move onto next phase
-NDA must be submitted to move on
-IND: Investigational new drug application
Durham-Humphrey Amendment of 1951
Established two classes of drugs: prescription vs OTC
Kefauver-Harris Agreement of 1962
required all new drugs marketed in US to be safe and effective (following thalidomide)
-prescription drug advertising falls under FDA
Comprehensive Drug Abuse Prevention and Control Act of 1970
-Created five categories of controlled substances
-Drug Enforcement Agency created in 1973 to enforce
Biosimilars (“branded generics”)
aka off brand
-Need prescription to match drug name, not interchangeable with name brand
-must write new prescription to receive biosimilar from pharmacy
FDA approved vs off-label
If a drug wants FDA approval for another indication, it has to go through the FDA approval process for that indication
Three types of prescription drug advertising:
1. Product claim ads
only type of ads that name a drug and discuss its benefits and risks
-must include name of drug (brand and generic), at least one FDA approved use, most significant risks
reminder advertisements
can give name of drug, not the drug’s use
-does not contain good or bad info about the drug
-not allowed for certain prescription drugs with serious risks (black box warning)
help seeking ads
can describe disease or condition, but not recommend a specific drug treatment
-allowed to include a company’s name and tele number for more info
Check powerpoint for abbreviations (introduction to pharm)
Check powerpoint for abbreviations (introduction to pharm)
Catecholamines:
NE, E, dopamine
Somatic Nervous System: neurotransmitter/receptor type
Ach, nicotinic receptors (rapid signals compared to muscarinic G-proteins)